PharmAla Reaches Agreement in Principle to Supply MDMA to Clinical Trial in Exchange for ...
Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, ...
manilatimes18 小时
RenovoRx Reports Third Quarter 2024 Financial Results and Operational Highlights
RenovoRx, Inc. ("RenovoRx” or the "Company”) (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and offering RenovoCath, a novel, FDA-cleared local drug-delivery ...